Shelton Capital Management purchased a new position in shares of Hill-Rom Holdings Inc (NYSE:HRC) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 4,543 shares of the medical technology company’s stock, valued at approximately $362,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Independent Portfolio Consultants Inc. boosted its holdings in shares of Hill-Rom Holdings by 171.5% during the second quarter. Independent Portfolio Consultants Inc. now owns 1,344 shares of the medical technology company’s stock worth $107,000 after acquiring an additional 849 shares during the period. Seven Eight Capital LP bought a new stake in shares of Hill-Rom Holdings during the second quarter worth approximately $127,000. Acrospire Investment Management LLC boosted its holdings in shares of Hill-Rom Holdings by 43.4% during the second quarter. Acrospire Investment Management LLC now owns 1,983 shares of the medical technology company’s stock worth $158,000 after acquiring an additional 600 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Hill-Rom Holdings by 10.2% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,201 shares of the medical technology company’s stock worth $175,000 after acquiring an additional 204 shares during the period. Finally, Citigroup Inc. boosted its holdings in shares of Hill-Rom Holdings by 21.1% during the second quarter. Citigroup Inc. now owns 2,483 shares of the medical technology company’s stock worth $198,000 after acquiring an additional 433 shares during the period. 82.31% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Hill-Rom Holdings Inc (HRC) opened at 78.36 on Friday. The company has a market capitalization of $5.16 billion, a PE ratio of 45.66 and a beta of 1.19. Hill-Rom Holdings Inc has a 52 week low of $50.50 and a 52 week high of $84.65. The company has a 50 day moving average price of $75.64 and a 200 day moving average price of $76.10.

Hill-Rom Holdings (NYSE:HRC) last released its quarterly earnings data on Friday, July 28th. The medical technology company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Hill-Rom Holdings had a net margin of 4.27% and a return on equity of 19.99%. The business had revenue of $689.10 million during the quarter, compared to analyst estimates of $695.50 million. During the same period in the previous year, the business earned $0.81 EPS. Hill-Rom Holdings’s revenue was up 5.1% compared to the same quarter last year. On average, equities research analysts expect that Hill-Rom Holdings Inc will post $3.82 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, September 29th. Shareholders of record on Friday, September 15th were issued a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.92%. The ex-dividend date of this dividend was Thursday, September 14th. Hill-Rom Holdings’s payout ratio is 41.62%.

In other Hill-Rom Holdings news, SVP Andreas G. Frank sold 6,870 shares of the firm’s stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $77.48, for a total value of $532,287.60. Following the completion of the transaction, the senior vice president now directly owns 16,701 shares of the company’s stock, valued at approximately $1,293,993.48. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Andreas G. Frank sold 3,940 shares of the firm’s stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $77.84, for a total transaction of $306,689.60. Following the completion of the transaction, the senior vice president now directly owns 16,701 shares of the company’s stock, valued at $1,300,005.84. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.

A number of equities research analysts have recently issued reports on the company. Cantor Fitzgerald set a $86.00 price objective on Hill-Rom Holdings and gave the stock a “hold” rating in a report on Friday, July 28th. Zacks Investment Research upgraded Hill-Rom Holdings from a “sell” rating to a “hold” rating in a report on Monday, September 18th. BidaskClub cut Hill-Rom Holdings from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Morgan Stanley boosted their price objective on Hill-Rom Holdings from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Friday, June 30th. Finally, Needham & Company LLC reduced their price objective on Hill-Rom Holdings from $95.00 to $93.00 and set a “buy” rating for the company in a report on Friday, July 28th. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $87.80.

WARNING: “Shelton Capital Management Purchases Shares of 4,543 Hill-Rom Holdings Inc (HRC)” was posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this story on another publication, it was illegally copied and republished in violation of U.S. and international copyright and trademark laws. The original version of this story can be viewed at https://theolympiareport.com/2017/10/13/shelton-capital-management-purchases-shares-of-4543-hill-rom-holdings-inc-hrc.html.

About Hill-Rom Holdings

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.